Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 3Dermatologic 3Other 2Lymphoid 2Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Prostatic Neoplasms 1216Urinary Bladder Neoplasms 387Carcinoma, Renal Cell 329Kidney Neoplasms 205Neoplasms 157Breast Neoplasms 146Lung Neoplasms 101Carcinoma, Transitional Cell 100Colorectal Neoplasms 77Testicular Neoplasms 74Ovarian Neoplasms 62Melanoma 60Pancreatic Neoplasms 57Colonic Neoplasms 50Carcinoma, Non-Small-Cell Lung 50Head and Neck Neoplasms 47Disease 47Stomach Neoplasms 45Non-Muscle Invasive Bladder Neoplasms 45Neoplasm Metastasis 41Liver Neoplasms 40Uterine Cervical Neoplasms 39Esophageal Neoplasms 37Wilms Tumor 36Prostatic Hyperplasia 36Adenocarcinoma 33Multiple Myeloma 32Urologic Neoplasms 30Sarcoma 30Recurrence 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Peripheral Arterial Disease × Genitourinary × Clear all
NCT03987633 2025-03-10

EMPOWER

Future Genetics Limited

Recruiting
200,000 enrolled
GenitourinaryOtherThoracic

Ischemic Stroke, Arthritis, Rheumatoid, Asthma, Atrial Fibrillation, Mental Disorders, Cardiovascular Diseases, Coronary Disease, Dementia, Depression, Diabetes Mellitus, Epilepsy, Heart Failure, Hypertension, Lung Neoplasms, Neoplasms, Obesity, Prostatic Neoplasms, Pulmonary Disease, Chronic Obstructive, Renal Insufficiency, Chronic, Peripheral Arterial Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡